Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
Jake Dunning(University of Oxford), Benjamin Hope-Gill(Cardiff and Vale University Health Board), Ian Goodfellow(University of Cambridge), Andrew J. H. Simpson(University of Hull), Jennifer Grove(University of Oxford), Raul Pardinaz-Solis(University of Oxford), Mauricio Ferri(University of Calgary), Mark Kowalski(College of San Mateo), Amanda Rojek(University of Oxford), Lucy Thorne(University College London), Foday Sahr(Sierra Leone Urban Research Centre), Regina Gandi, Thomas Massaquoi, Piero Olliaro(University of Oxford), Peter Horby, Trudie Lang(Angkor Hospital for Children), Gail Carson, Fiona Gannon(Dún Laoghaire Institute of Art, Design and Technology), Armando Arias(University of Cambridge), Sebatu Joseph, Laura Merson, Rebecca Howell‐Jones(Centre international de recherche sur le cancer), Hassan K. Osman, Kasia Stepniewska(Churchill Hospital), John Whitehead(Lancaster City Council), L Castle, Timothy Brooks(Public Health England), Baimba Idriss, Mohammed Samai(University of Sierra Leone)
Cited by 167
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
|International Journal of Cancer|2010|1.1k